Contact this trialFirst, we need to learn more about you.
Evuzamitide Imaging for Amyloidosis
Recruiting1 awardPhase 2
New York, New York
This trial will assess if 124I-evuzamitide PET scanning can identify ATTR-CM in patients with heart failure and increased wall thickness not currently diagnosed with ATTR-CM.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.